Looking back to 57 days ago, Integra LifeSciences Holdings Corp (IART) priced a 3,500,000 share secondary stock offering at $40.00 per share. Buyers in that offering made a considerable investment into the company, expecting that their investment would go up over the course of time and based on early trading on Thursday, the stock is now 17.2% higher than the offering price.
Investors who did not participate in the offering but would be a buyer of IART at a cheaper price, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the June put at the $35 strike, which has a bid at the time of this writing of 50 cents. That would result in a cost basis of $34.50 per share before broker commissions in the scenario where the contract is exercised. If the contract is never exercised, the put seller would still keep the premium, which represents a 1.4% return against the $35.00 purchase commitment, or a 3.1% annualized rate of return (at Stock Options Channel we call this the YieldBoost). START SLIDESHOW:
Top YieldBoost Puts of of Stocks with Recent Secondaries »